Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
One of the problems with prostate cancer is that it can take many years for the disease to develop from a very small group of cells in a man’s prostate into a disorder that has actual clinical significance.
Filed under: Diagnosis, Risk | Tagged: clinically significant, early stage, ethics, Malmo, prognosis, trial | Leave a Comment »
The collaborative research between the teams at Memorial Sloan-Kettering Cancer Center in New York and in Malmö in Sweden continues to refine a model that may allow us to accurately predict which patients are at clinically significant risk for prostate cancer based solely on simple tests run on a single blood sample.
Filed under: Diagnosis, Risk, Uncategorized | Tagged: biopsy, clinically significant, kallikrein, prediction, PSA, risk | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site